<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1028-4818</journal-id>
<journal-title><![CDATA[Multimed]]></journal-title>
<abbrev-journal-title><![CDATA[Multimed]]></abbrev-journal-title>
<issn>1028-4818</issn>
<publisher>
<publisher-name><![CDATA[Centro Provincial de Información de Ciencias Médicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1028-48182020000200399</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Valor pronóstico de la hemoglobina glicada HbA1c en el padecimiento de retinopatía diabética en pacientes con diabetes mellitus tipo II]]></article-title>
<article-title xml:lang="en"><![CDATA[Prognostic value of glycated hemoglobin HbA1c in diabetic retinopathy in patients with type II diabetes mellitus]]></article-title>
<article-title xml:lang="pt"><![CDATA[Valor prognóstico da hemoglobina glicada HbA1c na retinopatia diabética em pacientes com diabetes mellitus tipo II]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rodríguez Martínez.]]></surname>
<given-names><![CDATA[Madelín]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Soler Otero.]]></surname>
<given-names><![CDATA[José Antonio]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Brizuela Labrada.]]></surname>
<given-names><![CDATA[Oleydis]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Santisteban Sánchez.]]></surname>
<given-names><![CDATA[Hugo Norge]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Berro Zamora.]]></surname>
<given-names><![CDATA[Augusto Leandro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Ciencias Médicas de Granma Facultad de Ciencias Médicas Celia Sánchez Manduley ]]></institution>
<addr-line><![CDATA[Manzanillo Granma]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Clínico Quirúrgico Docente Celia Sánchez Manduley  ]]></institution>
<addr-line><![CDATA[Manzanillo Granma]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>04</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>04</month>
<year>2020</year>
</pub-date>
<volume>24</volume>
<numero>2</numero>
<fpage>399</fpage>
<lpage>415</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1028-48182020000200399&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1028-48182020000200399&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1028-48182020000200399&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN Se realizó un estudio analítico transversal, con el objetivo de establecer el valor pronóstico de la hemoglobina glicada en la aparición de la retinopatía diabética en la Policlínica Universitaria Ángel Ortiz Vázquez. 2015-2019.El universo estuvo constituido por 181 pacientes con diagnóstico de diabetes mellitus tipo II, cada paciente fue seguido por dos años realizándose tres hemoglobinas glicada, tres glicemias en ayuna y dos controles oftalmológicos. Se observó una relación incremental del riesgo de retinopatía diabética según el nivel de hemoglobina glicada ascendente fundamentada en el incremento en la tendencia del riesgo asociado para retinopatía diabética, desde casi el doble (OR=1.89) con cifras de HbA1c entre 7.1 y 8.0 hasta más del triple (OR=3.51) cuando los valores de HbA1c fueron iguales o mayores a 10.1. La presencia de retinopatía diabética está en relación con los niveles de hemoglobina glicada, hecho que responde a un control glucémico inapropiado sostenido, que además promueve la aparición de otras complicaciones crónicas de la enfermedad.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT A cross-sectional analytical study was carried out, with the objective of establishing the prognostic value of glycated hemoglobin in the appearance of diabetic retinopathy at the Ángel Ortiz Vázquez University Polyclinic. 2015-2019. The universe was made up of 181 patients diagnosed with type II diabetes mellitus, each patient was followed for two years with three glycated hemoglobins, three fasting glycemia and two ophthalmological controls. An incremental relationship of the risk of diabetic retinopathy was observed according to the level of ascending glycated hemoglobin based on the increase in the trend of the associated risk for diabetic retinopathy, from almost double (OR = 1.89) with HbA1c figures between 7.1 and 8.0 to more. triple (OR = 3.51) when HbA1c values &#8203;&#8203;were equal to or greater than 10.1. The presence of diabetic retinopathy is related to the levels of glycated hemoglobin, a fact that responds to sustained inappropriate glycemic control, which also promotes the appearance of other chronic complications of the disease.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[RESUMO Foi realizado um estudo analítico transversal, com o objetivo de estabelecer o valor prognóstico da hemoglobina glicada no aparecimento de retinopatia diabética na Policlínica da Universidade Ángel Ortiz Vázquez. 2015-2019. O universo foi constituído por 181 pacientes com diagnóstico de diabetes mellitus tipo II; cada paciente foi acompanhado por dois anos com três hemoglobinas glicadas, três glicemia de jejum e dois controles oftalmológicos. Foi observada uma relação incremental do risco de retinopatia diabética de acordo com o nível de hemoglobina glicada ascendente, com base no aumento da tendência do risco associado à retinopatia diabética, de quase o dobro (OR = 1,89) com valores de HbA1c entre 7,1 e 8,0 para mais. triplo (OR = 3,51 quando os valores de HbA1c forem iguais ou superiores a 10,1. A presença de retinopatia diabética está relacionada aos níveis de hemoglobina glicada, fato que responde ao controle glicêmico inadequado sustentado, que também promove o aparecimento de outras complicações crônicas da doença.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Diabetes mellitus tipo 2]]></kwd>
<kwd lng="es"><![CDATA[Retinopatía diabética]]></kwd>
<kwd lng="es"><![CDATA[Hemoglobina glucada]]></kwd>
<kwd lng="en"><![CDATA[Diabetes mellitus type 2]]></kwd>
<kwd lng="en"><![CDATA[Diabetic retinopathy]]></kwd>
<kwd lng="en"><![CDATA[Glycated hemoglobin]]></kwd>
<kwd lng="pt"><![CDATA[Diabetes mellitus tipo 2]]></kwd>
<kwd lng="pt"><![CDATA[Retinopatia diabética]]></kwd>
<kwd lng="pt"><![CDATA[Hemoglobina glicada]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hernández Ruiz de Eguilaz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Batlle]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez de Morentin]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[San Cristóbal]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez Díez]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Navas Carretero]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cambios alimentarios y de estilo de vida como estrategia en la prevención del síndrome metabólico y la diabetes mellitus tipo 2 hitos y perspectivas.]]></article-title>
<source><![CDATA[An. Sist. Sanit. Navar]]></source>
<year>2016</year>
<volume>39</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>269-89</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<collab>Ministerio de Salud y Protección Social</collab>
<source><![CDATA[Guía de práctica clínica para el diagnóstico, tratamiento y seguimiento de la diabetes mellitus tipo 2 en la población mayor de 18 años.]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Colombia ]]></publisher-loc>
<publisher-name><![CDATA[MINSALUD]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Llorente Columbié]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Miguel Soca]]></surname>
<given-names><![CDATA[PE]]></given-names>
</name>
<name>
<surname><![CDATA[Rivas Vázquez]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Borrego Chi]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores de riesgo asociados con la aparición de diabetes mellitus tipo 2 en personas adultas]]></article-title>
<source><![CDATA[Rev Cubana Endocrinol]]></source>
<year>2016</year>
<volume>27</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<collab>Organización Mundial de la Salud</collab>
<source><![CDATA[Informe mundial sobre la diabetes.]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Ginebra ]]></publisher-loc>
<publisher-name><![CDATA[OMS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Torres Hernández]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[González Jímenez]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández Ojeda]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Gutiérrez Aguilar]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Amaya Herrera]]></surname>
<given-names><![CDATA[LD]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[OH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hiperglucemia persistente asociada a Retinopatía Diabética en Pacientes Diabéticos tipo 2 de la Ciudad de Veracruz]]></article-title>
<source><![CDATA[Rev Mex Med Forense]]></source>
<year>2019</year>
<volume>4</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>24-33</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mesa]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Falcón de legal]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Velasco García]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Salud Jiménez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guías ALAD sobre el Diagnóstico, Control y Tratamiento de la Diabetes Mellitus Tipo 2 con Medicina Basada en Evidencia Edición 2019]]></article-title>
<source><![CDATA[Rev ALAD]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gómez Encino]]></surname>
<given-names><![CDATA[GC]]></given-names>
</name>
<name>
<surname><![CDATA[Cruz León]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Zapata Vázquez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Morales Ramón]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nivel de conocimiento que tienen los pacientes con Diabetes Mellitus tipo 2 en relación a su enfermedad.]]></article-title>
<source><![CDATA[Salud en Tabasco]]></source>
<year>2015</year>
<volume>21</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>17-25</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Xu]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Zou]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Han]]></surname>
<given-names><![CDATA[QJ]]></given-names>
</name>
<name>
<surname><![CDATA[Hu]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intensive glycemic control and macrovascular events in type 2 diabetes mellitus a meta-analysis of randomized controlled trials]]></article-title>
<source><![CDATA[Chin Med J]]></source>
<year>2010</year>
<volume>123</volume>
<numero>20</numero>
<issue>20</issue>
<page-range>2908-13</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Llorente Columbié]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Miguel Soca]]></surname>
<given-names><![CDATA[PE]]></given-names>
</name>
<name>
<surname><![CDATA[Rivas Vázquez]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Borrego Chi]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores de riesgo asociados con la aparición de diabetes mellitus tipo 2 en personas adultas]]></article-title>
<source><![CDATA[Rev Cubana Endocrinol]]></source>
<year>2016</year>
<volume>27</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>123-33</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cardellá Hernández]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández Fernández]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Bioquímica Médica]]></source>
<year>2014</year>
<edition>2da</edition>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Ciencias Médicas]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez Guanare]]></surname>
<given-names><![CDATA[Ml]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Edema macular diabético Definición, epidemiología, factores de riego, patogénesis, diagnóstico y clasificación.]]></article-title>
<source><![CDATA[Rev. ALAD]]></source>
<year>2015</year>
<volume>5</volume>
<page-range>98-105</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pérez Paéz]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez Weber]]></surname>
<given-names><![CDATA[FL]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz Greene]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
<name>
<surname><![CDATA[Cabrera Jardines]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mitos y realidad de la hemoglobina glucosilada]]></article-title>
<source><![CDATA[Med Int Mex]]></source>
<year>2009</year>
<volume>25</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>202-9</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arnal Meinhardt]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hemoglobina alta ¿causa problemas?]]></article-title>
<source><![CDATA[Segundo Medico.com]]></source>
<year>2015</year>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ávila]]></surname>
<given-names><![CDATA[AY]]></given-names>
</name>
<name>
<surname><![CDATA[Lima]]></surname>
<given-names><![CDATA[GV]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Retinopatía que amenaza la visión en pacientes diabéticos no referidos al oftalmólogo]]></article-title>
<source><![CDATA[Gaceta Médica de México]]></source>
<year>2013</year>
<volume>149</volume>
<page-range>624-9</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="book">
<collab>International Diabetes Federation</collab>
<source><![CDATA[Atlas de la Diabetes]]></source>
<year>2017</year>
<edition>8va</edition>
<publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[IDF]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="book">
<collab>Cuba</collab>
<collab>Ministerio de Salud Pública</collab>
<source><![CDATA[Anuario Estadístico de Salud, 2017.]]></source>
<year>2018</year>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[MINSAP]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pinheiro]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hemoglobina Glicosilada: Valores normales y cómo bajarla]]></article-title>
<source><![CDATA[Mdsaude.com]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rojas Canchala]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Troya Ronquillo]]></surname>
<given-names><![CDATA[PC]]></given-names>
</name>
</person-group>
<source><![CDATA[Grados de retinopatía diabética en pacientes diabéticos tipo 2 con enfermedad renal crónica estadio v, sometidos a hemodiálisis en el Hospital "Eugenio Espejo" en el período de junio 2013-mayo 2014.]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Quito ]]></publisher-loc>
<publisher-name><![CDATA[Universidad Central del Ecuador]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez Villalobos]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Ramírez Barba]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
<name>
<surname><![CDATA[Cervantes-Aguayo]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Vargas Salado]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Ávalos Muñoz]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Incidencia y progresión de la retinopatía diabética en diabetes mellitus 2, a seis años]]></article-title>
<source><![CDATA[Diabet Hoy MedSal]]></source>
<year>2004</year>
<volume>15</volume>
<page-range>1262-73</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Leyton Núñez]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Sepúlveda Grubessich]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Estudio de la prevalencia de la retinopatía diabética en pacientes diagnosticados con diabetes mellitus tipo II atendidos en el centro de atención primaria de salud viña del mar (caps), de la dirección de sanidad general de la armada de chile]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Valparaíso, México ]]></publisher-loc>
<publisher-name><![CDATA[Pontificia Universidad Católica de Valparaíso]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Storino]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Contreras]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Rojano]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Serrano]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Nouel]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Complicaciones de la diabetes y su asociación con el estrés oxidativo un viaje hacia el daño endotelial]]></article-title>
<source><![CDATA[Rev Colomb Cardiol]]></source>
<year>2014</year>
<volume>21</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>392-8</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bejan Angoulvant]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Cornu]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Archambault]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Tudrej]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Audier]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Brabant]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Is HbA1c a valid surrogate for macrovascular and microvascular complications in type 2 diabetes]]></article-title>
<source><![CDATA[Diabetes Metab]]></source>
<year>2015</year>
<volume>41</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>195-201</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Albuja Arias]]></surname>
<given-names><![CDATA[XP]]></given-names>
</name>
<name>
<surname><![CDATA[Páez Iturralde]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<source><![CDATA[Niveles de hemoglobina glicosilada asociados a retinopatía diabética en pacientes del hospital general de las fuerzas armadas de la ciudad de quito. Periodo 2010-2011.]]></source>
<year>2013</year>
<publisher-loc><![CDATA[Ecuador ]]></publisher-loc>
<publisher-name><![CDATA[Universidad Central del Ecuador]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Díaz]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
<name>
<surname><![CDATA[Orejuela]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pinza]]></surname>
<given-names><![CDATA[Ll]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores relacionados con el control metabólico de pacientes con diabetes mellitus tipo 2 atendidos en tres hospitales de la ciudad de Quito-Ecuador]]></article-title>
<source><![CDATA[Rev Méd Vozandes]]></source>
<year>2012</year>
<volume>23</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>5-14</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="book">
<collab>National Eye Institute</collab>
<source><![CDATA[La retinopatía diabética]]></source>
<year>2019</year>
<publisher-loc><![CDATA[Bethesda, Maryland, E.U ]]></publisher-loc>
<publisher-name><![CDATA[NEI]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
